MAM
OMIC

Marquette Asset Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Marquette Asset Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,432
Closed -$39.2K – 305
2023
Q3 		$39.2K Sell
3,432
-1,132
-25% -$21K 0.01% 145
2023
Q2 		$114K Buy
4,564
+3,347
+275% +$98.1K 0.03% 111
2023
Q1 		$44.2K Hold
1,217
– – 0.01% 151
2022
Q4 		$73.4K Buy
+1,217
New +$81.6K 0.02% 132

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marquette Asset Management's OMIC Position: Q4 2023 in Review

Marquette Asset Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2023, closing a stake of 3,432 shares — an estimated $39.2K sold.

Marquette Asset Management first reported a position in OMIC in Q4 2022 and held it in 4 quarters. The position peaked at $114K in Q2 2023. 47 funds tracked by Wall St. Rank hold OMIC as of Q4 2023.

  • Marquette Asset Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Marquette Asset Management sold 3,432 Singular Genomics Systems, Inc. Common Stock shares in Q4 2023, an estimated $39.2K.
  • Marquette Asset Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Marquette Asset Management's Singular Genomics Systems, Inc. Common Stock position peaked at $114K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2023.

Based on Marquette Asset Management's 13F filing for Q4 2023, filed 2 Feb 2024.